Want to join the conversation?
$DPRX said the European Patent Office has issued a new Locilex patent in the European Union (EU). The patent claims are directed to novel formulation of Locilex, topical antimicrobial peptide formulated as topical cream, and use of Locilex as method of treating skin or wound infections. The issued patent has expiry date in June 2033.
Still in yesterday’s $PZZA shock. I thought everyone had more pizza this football season!!
$TSLA stock downgraded to sell from hold by brokerage firm CFRA Research. However, the firm lifted the price target by $35 to $240.
$LB shares have plummeted after a disappointing quarter.